Cencora, Inc. (COR) stock
CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 14/3021% above fair value
$348.31−2.25 (-0.64%)
Close on Nov 18, 2026Market cap $66.47BP/E 25.9Yield 0.63%
Cencora net income
Net income is the profit left for shareholders after every expense, interest and tax.
Cencora's net income for the twelve months ending Jun 30, 2026 was $2.62B, up 38.3% year over year. For fiscal 2025 it was $1.55B, up 3.0% from the year before. The highest annual figure on record is $1.75B in fiscal 2023.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.55B | +3.0% |
| FY2024 | Sep 30, 2024 | $1.51B | -13.5% |
| FY2023 | Sep 30, 2023 | $1.75B | +2.7% |
| FY2022 | Sep 30, 2022 | $1.70B | +10.3% |
| FY2021 | Sep 30, 2021 | $1.54B | – |
| FY2020 | Sep 30, 2020 | -$3.41B | -498.5% |
| FY2019 | Sep 30, 2019 | $855.37M | -48.4% |
| FY2018 | Sep 30, 2018 | $1.66B | +355.0% |
| FY2017 | Sep 30, 2017 | $364.48M | -74.5% |
| FY2016 | Sep 30, 2016 | $1.43B | – |
| FY2015 | Sep 30, 2015 | -$138.17M | -150.4% |
| FY2014 | Sep 30, 2014 | $274.23M | -36.8% |
| FY2013 | Sep 30, 2013 | $433.71M | -39.7% |
| FY2012 | Sep 30, 2012 | $718.99M | +1.7% |
| FY2011 | Sep 30, 2011 | $706.62M | +11.0% |
| FY2010 | Sep 30, 2010 | $636.75M | +26.5% |
| FY2009 | Sep 30, 2009 | $503.40M | +100.9% |
| FY2008 | Sep 30, 2008 | $250.56M | -46.6% |
| FY2007 | Sep 30, 2007 | $469.17M | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $763.52M | +11.1% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $1.64B | +128.6% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $559.65M | +14.5% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | -$339.70M | -10144.5% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $687.40M | +42.2% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $717.87M | +70.6% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $488.60M | -18.8% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $3.38M | -99.0% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $483.46M | +0.8% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $420.78M | -3.4% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $601.50M | +25.4% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $350.57M | +18.9% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $479.58M | +17.8% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $435.40M | -20.5% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $479.75M | +6.8% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $294.74M | -32.7% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $406.96M | +39.3% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $548.01M | +25.9% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $449.11M | +19.8% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $437.70M | – |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $292.12M | +0.9% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $435.27M | -54.7% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $374.85M | +99.8% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | -$4.85B | -3754.1% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $289.44M | -4.1% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $960.28M | +3438.9% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $187.64M | -52.3% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $132.62M | -43.2% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $301.96M | +9.5% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $27.14M | -90.6% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $393.65M | -54.3% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $233.29M | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $275.81M | +447.8% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $287.46M | -30.1% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $861.85M | +248.6% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | -$344.59M | -336.5% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $50.35M | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $411.47M | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $247.25M | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $145.69M | – |
See a number that looks wrong?